Genflow Biosciences plc (GENFF)
OTCMKTS · Delayed Price · Currency is USD
0.0250
0.00 (0.00%)
Sep 26, 2025, 9:30 AM EDT
Genflow Biosciences Market Cap
Genflow Biosciences has a market cap or net worth of $9.45 million as of September 29, 2025. Its market cap has decreased by -5.94% in one year.
Market Cap
9.45M
Enterprise Value
9.07M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since January 17, 2022, Genflow Biosciences's market cap has decreased from 45.94M to 9.45M, a decrease of -79.44%. That is a compound annual growth rate of -34.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 9.43M | 24.83% |
| Dec 31, 2024 | 7.55M | 42.24% |
| Dec 29, 2023 | 5.31M | -37.23% |
| Dec 30, 2022 | 8.46M | -81.59% |
| Jan 17, 2022 | 45.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 742.59M |
| Tian'an Technology Group | 718.73M |
| Glass House Brands | 516.60M |
| Northwest Biotherapeutics | 387.17M |
| CytoDyn | 332.57M |
| American Oncology Network | 305.31M |
| Nika Pharmaceuticals | 301.74M |